Enrique Poradosu - 06 Jan 2026 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: Chief Science & Business Off
Signature: /s/ Enrique Poradosu
Issuer symbol: NVCT
Transactions as of: 06 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2026, 16:30:55 UTC
Previous filing: 03 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Poradosu Enrique	Chief Science & Business Off	C/O NUVECTIS PHARMA, INC., 1 BRIDGE PLAZA, SUITE 275, FORT LEE	/s/ Enrique Poradosu	09 Jan 2026	0001898147

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Award	$0	+150,000	+9.1%	$0.000000	1,806,319	06 Jan 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 150,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Poradosu's continued service on such dates.
F2	Includes shares of restricted common stock.